EFEXOR XL

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

VENLAFAXINE HYDROCHLORIDE

Available from:

IPS Healthcare Limited

Dosage:

150 Milligram

Pharmaceutical form:

Prolonged Release Capsules

Authorization date:

2010-11-19

Summary of Product characteristics

                                
License
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Efexor XL 150mg Prolonged - release capsules, hard
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Efexor XL 150mg prolonged-release hard capsule contains 150mg of venlafaxine as venlafaxine hydrochloride.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Prolonged-release capsule, hard
Product imported from the United Kingdom:
Opaque dark orange capsules printed in white with ‘W’ and ’150’.  
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
Treatment of major depressive episodes.
For prevention of recurrence of major depressive episodes.
Treatment of generalised anxiety disorder.
Treatment of social anxiety disorder.
Treatment of panic disorder, with or without agoraphobia.
4.2 Posology and method of administration
Major depressive episodes
The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding
to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 375 mg/day. Dosage increases
can be made at intervals of 2 weeks or more. If clinically warranted due to symptom severity, dose increases can be
made at more frequent intervals, but not les
                                
                                Read the complete document
                                
                            

Search alerts related to this product

View documents history